Persisting multilineage transgene expression in the clonal progeny of a hematopoietic stem cell
- 30 August 2002
- journal article
- Published by Springer Nature in Leukemia
- Vol. 16 (9) , 1655-1663
- https://doi.org/10.1038/sj.leu.2402619
Abstract
Many applications of hematopoietic gene therapy require selection for clones with active transgene expression. However, it was unclear whether the clonal progeny of a retrovirally transduced hematopoietic stem cell would be capable of maintaining transgene expression through serial repopulation and multilineage differentiation. Such investigations require simultaneous analyses of clonality, multilineage activity and transgene copy numbers. Using a mouse model, the present study demonstrates that a single hematopoietic stem cell expressing a marker gene from one or two insertions of a simple retroviral vector actively maintains multilineage transgene expression in the vast majority (80-99%) of bone marrow and peripheral blood cells. Gene expression persisted through serial transplantations for at least 97 weeks post gene transfer and was observed in the lymphoid (B, T and NK cells), myeloid (CD11b(+), Gr-1(+)), erythroid (Ter119(+), mature red blood cells) and megakaryocytic (as indicated by platelets) progeny. Therefore, a single immunoselection for hematopoietic stem cells expressing the transgene in vivo was sufficient to establish a completely chimeric hematopoiesis. These observations imply that the retroviral vectors used in this study contain cis-elements that mediate expression through massive clonal expansion and multilineage differentiation, provided the insertion occurred in genetic loci permissive for expression in hematopoietic stem cells.Keywords
This publication has 38 references indexed in Scilit:
- In Vivo Analysis of Retroviral Enhancer Mutations in Hematopoietic Cells: SP1/EGR1 and ETS/GATA Motifs Contribute to Long Terminal Repeat SpecificityJournal of Virology, 2002
- Influence of multiplicity of infection and protein stability on retroviral vector-mediated gene expression in hematopoietic cellsGene Therapy, 2001
- CD34 Splice Variant: An Attractive Marker for Selection of Gene-Modified CellsMolecular Therapy, 2000
- Long-term silencing of retroviral vectors is resistant to reversal by trichostatin A and 5-azacytidineGene Therapy, 2000
- Multicentre European study comparing selection techniques for the isolation of CD34+ cellsBone Marrow Transplantation, 1999
- Selective Immunoaffinity-Based Enrichment of CD34+Cells Transduced with Retroviral Vectors Containing an Intracytoplasmatically Truncated Version of the Human Low-Affinity Nerve Growth Factor Receptor (ΔLNGFR) GeneHuman Gene Therapy, 1997
- Sustained High-Level Reconstitution of the Hematopoietic System by Preselected Hematopoietic Cells Expressing a Transduced Cell-Surface AntigenHuman Gene Therapy, 1997
- The prokaryotic neomycin-resistance-encoding gene acts as a transcriptional silencer in eukaryotic cellsGene, 1991
- Chromosomal position or virus mutation permits retrovirus expression in embryonal carcinoma cellsCell, 1986
- Anemic Stress as a Trigger of Myelogenous Leukemia in Rats Rendered Leukemia-Prone by X-rayScience, 1971